Quantum computing has quietly moved past the "someday" phase for a specific set of industries — more than 300 companies including Airbus, JPMorgan Chase, and Boehringer Ingelheim are now actively working with quantum vendors on real business problems, according to McKinsey's 2026 Quantum Technology Monitor — but the honest picture is a mix of genuinely promising pilots and a lot of work still stuck at proof-of-concept scale. Drug discovery, materials science, and logistics are the three areas furthest along, and each tells a different story about how close "useful" quantum computing actually is.
The Numbers Behind the Shift
McKinsey's fifth annual Quantum Technology Monitor, published in 2026, frames this as a genuine commercial tipping point rather than continued hype: over 300 organizations are actively collaborating with quantum technology companies to solve specific business problems, and first movers are described as transitioning from isolated pilots into applications embedded in actual end-to-end workflows. The firm estimates quantum computing could generate up to $2.7 trillion in global economic value by 2035, concentrated heavily in chemicals ($450–800 billion), financial services ($400–600 billion), and travel and logistics ($200–500 billion) — though McKinsey is careful to note that the bulk of that value lands in the 2030–2035 window, not before. On the revenue side, quantum computing companies collectively generated more than $1 billion in 2025, a figure McKinsey projects could reach $4.4 billion by 2028.
Drug Discovery: Real Partnerships, Small Molecules So Far
Pharmaceutical companies have become some of the most visible adopters. Google and Boehringer Ingelheim have demonstrated quantum simulation of Cytochrome P450 — an enzyme central to how the body metabolizes drugs — with greater precision than classical simulation methods achieve, directly relevant to predicting drug interactions before expensive trial phases. Roche has partnered with quantum computing firms on similar molecular simulation work, and IBM runs its own quantum chemistry collaborations with pharmaceutical partners.
The honest caveat matters here: these demonstrations have so far simulated small molecules, not the large, clinically relevant compounds that would actually reshape drug development timelines. Current hardware still lacks the qubit counts and error rates required for practically useful molecular simulation at scale. The commonly cited commercial timeline for quantum molecular simulation to meaningfully accelerate drug discovery is 5 to 10 years, contingent on systems reaching hundreds of error-corrected logical qubits — a bar that connects directly back to the logical-qubit efficiency race between Quantinuum and IonQ covered earlier in this series.
Materials Science: Airbus's Multi-Year Quantum Program
Airbus runs one of the most structured enterprise quantum programs in any industrial sector, with dedicated tracks for aerodynamics, manufacturing logistics, and climate modeling. Its ongoing wing-design work uses quantum optimization to search for aerodynamic and fuel-efficiency improvements that classical simulation methods struggle to reach efficiently. The company's Airbus Quantum Challenge, now in its third iteration as of 2026, has expanded its partner roster to include Cleveland Clinic, HSBC, E.ON, and Volkswagen, with this round focused on modeling that can accurately predict aerodynamic flows at the edge of an aircraft's operating envelope.
The 2024 Airbus-BMW Quantum Computing Challenge — a separate, earlier competition focused on supply chain and mobility problems — was won by French photonics company Quandela, and the underlying research documentation shows real, named collaboration between Airbus, Amazon Web Services, and IonQ engineers working directly on a multi-objective supply chain optimization problem using IonQ's trapped-ion hardware through AWS. That's a useful data point: some of this work is genuinely running on production quantum hardware today, not just simulated on classical machines pretending to be quantum.
Logistics: The QANTAS Crew-Scheduling Proof-of-Concept
Logistics and scheduling problems are widely considered among the most quantum-ready use cases, because they're fundamentally optimization problems — finding the best solution among an enormous number of possibilities — which maps well onto both true quantum algorithms and "quantum-inspired" classical approaches that borrow quantum math without needing quantum hardware. QANTAS ran a landmark proof-of-concept with Airbus and IBM Quantum for flight crew scheduling, one of the most computationally demanding combinatorial problems in commercial aviation: assigning crews to more than 40,000 flights annually while satisfying fatigue regulations, training requirements, base restrictions, and union agreements simultaneously. The project demonstrated the scale of the problem and the real limitations of current hardware, while establishing QANTAS's broader quantum capability roadmap rather than replacing its existing scheduling systems outright.
More broadly, quantum-inspired optimization — techniques that mimic quantum annealing approaches on classical hardware — is already reported to improve logistics efficiency by 10 to 30% in trials run by global manufacturers and airlines, which is arguably the more commercially mature story right now than true quantum hardware deployment.
How Real Is This, Honestly?
The field itself has a name for exactly where things stand: the NISQ era, short for Noisy Intermediate-Scale Quantum. Current hardware is powerful enough to run meaningful experiments and pilots, but not yet reliable enough to fully replace classical methods on production-critical workloads. The practical path most of these case studies actually take is hybrid — pairing quantum processors with classical high-performance computing, using the quantum side as an accelerator for specific sub-problems rather than running the entire workflow on quantum hardware. That's a genuinely useful stepping stone, but it also means most of the headline collaborations named above are still pilots and proofs-of-concept, not production replacements for classical systems.
Case Studies at a Glance
| Industry | Companies involved | What was tested | Status as of 2026 |
|---|---|---|---|
| Drug discovery | Google, Boehringer Ingelheim, Roche, IBM | Quantum simulation of drug-metabolizing enzymes and small molecules | Pilot / research stage; small molecules only |
| Materials science / aerospace | Airbus, Cleveland Clinic, HSBC, E.ON, Volkswagen | Aerodynamic flow modeling, wing design optimization | Ongoing multi-year challenge, third iteration |
| Logistics / supply chain | QANTAS, Airbus, IBM Quantum, BMW, IonQ, AWS | Flight crew scheduling; multi-objective supply chain optimization | Proof-of-concept; real hardware runs on specific sub-problems |
Frequently Asked Questions
Is quantum computing actually being used commercially in 2026, or is it still just research?
Both, depending on the use case. According to McKinsey, over 300 companies are actively collaborating with quantum vendors, and some work — like IonQ's involvement in Airbus-BMW supply chain optimization — runs on real quantum hardware today. But most headline case studies remain pilots and proofs-of-concept rather than production replacements for classical systems.
How much economic value could quantum computing create?
McKinsey estimates quantum computing could generate up to $2.7 trillion in global economic value by 2035, concentrated mainly in chemicals, financial services, and travel and logistics. The firm notes most of that value is expected in the 2030–2035 window rather than before.
Why is drug discovery considered a strong quantum use case?
Drug discovery depends heavily on simulating molecular interactions, a problem that scales exponentially on classical computers but maps naturally onto quantum mechanics. Google and Boehringer Ingelheim have already demonstrated more precise simulation of a key drug-metabolism enzyme than classical methods achieve, though current demonstrations are limited to small molecules.
What is "quantum-inspired" optimization, and is it different from real quantum computing?
Quantum-inspired optimization uses algorithms based on quantum mathematical principles but runs entirely on classical hardware, without needing an actual quantum computer. It's already delivering measurable logistics efficiency gains of 10–30% in some trials, making it a more commercially mature option today than true quantum hardware deployment.